![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | decreases expression | ISO | RGD:732901 | 6480464 | 1, 2-Dimethylhydrazine results in decreased expression of FBXO2 mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | multiple interactions | ISO | RGD:732901 | 6480464 | Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in decreased expression of FBXO2 mRNA] | CTD | PMID:22206623 | 17beta-estradiol | decreases expression | ISO | RGD:732900 | 6480464 | Estradiol results in decreased expression of FBXO2 mRNA | CTD | PMID:31614463 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:732900 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of FBXO2 mRNA | CTD | PMID:20106945, PMID:21632981 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of FBXO2 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:732900 | 6480464 | Tetrachlorodibenzodioxin affects the expression of FBXO2 mRNA | CTD | PMID:22298810, PMID:22574217 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:732901 | 6480464 | Tetrachlorodibenzodioxin affects the expression of FBXO2 mRNA | CTD | PMID:21570461 | 2-methoxyethanol | decreases expression | EXP | | 6480464 | methyl cellosolve results in decreased expression of FBXO2 mRNA | CTD | PMID:19643169 | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of FBXO2 mRNA | CTD | PMID:24780913 | aflatoxin B1 | decreases expression | ISO | RGD:732900 | 6480464 | Aflatoxin B1 results in decreased expression of FBXO2 mRNA | CTD | PMID:27153756 | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of FBXO2 mRNA | CTD | PMID:16483693 | antirheumatic drug | affects expression | ISO | RGD:732900 | 6480464 | Antirheumatic Agents affects the expression of FBXO2 mRNA | CTD | PMID:24449571 | atrazine | increases expression | ISO | RGD:732900 | 6480464 | Atrazine results in increased expression of FBXO2 mRNA | CTD | PMID:22378314 | benzo[a]pyrene | decreases expression | ISO | RGD:732901 | 6480464 | Benzo(a)pyrene results in decreased expression of FBXO2 mRNA | CTD | PMID:19770486 | benzo[a]pyrene | increases methylation | ISO | RGD:732900 | 6480464 | Benzo(a)pyrene results in increased methylation of FBXO2 3' UTR | CTD | PMID:27901495 | benzo[a]pyrene | increases expression | ISO | RGD:732900 | 6480464 | Benzo(a)pyrene results in increased expression of FBXO2 mRNA | CTD | PMID:20106945 more ... | benzo[a]pyrene | increases expression | ISO | RGD:732901 | 6480464 | Benzo(a)pyrene results in increased expression of FBXO2 mRNA | CTD | PMID:22228805 | bis(2-ethylhexyl) phthalate | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of FBXO2 promoter | CTD | PMID:23359474 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of FBXO2 promoter | CTD | PMID:23359474 | bisphenol A | increases expression | ISO | RGD:732901 | 6480464 | bisphenol A results in increased expression of FBXO2 mRNA | CTD | PMID:32156529 | bisphenol A | decreases expression | ISO | RGD:732901 | 6480464 | bisphenol A results in decreased expression of FBXO2 mRNA | CTD | PMID:35598803 | bisphenol A | increases methylation | ISO | RGD:732901 | 6480464 | bisphenol A results in increased methylation of FBXO2 promoter | CTD | PMID:27312807 | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of FBXO2 gene | CTD | PMID:28505145 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of FBXO2 mRNA | CTD | PMID:25181051, PMID:34947998 | C60 fullerene | decreases expression | EXP | | 6480464 | fullerene C60 results in decreased expression of FBXO2 mRNA | CTD | PMID:19167457 | cadmium dichloride | decreases expression | ISO | RGD:732900 | 6480464 | Cadmium Chloride results in decreased expression of FBXO2 mRNA | CTD | PMID:26472689 | calcitriol | increases expression | ISO | RGD:732900 | 6480464 | Calcitriol results in increased expression of FBXO2 mRNA | CTD | PMID:26485663 | chrysene | decreases expression | ISO | RGD:732901 | 6480464 | chrysene results in decreased expression of FBXO2 mRNA | CTD | PMID:26377693 | cisplatin | increases expression | ISO | RGD:732900 | 6480464 | Cisplatin results in increased expression of FBXO2 mRNA | CTD | PMID:27392435 | cisplatin | multiple interactions | ISO | RGD:732900 | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of FBXO2 mRNA | CTD | PMID:27392435 | copper(II) sulfate | increases expression | ISO | RGD:732900 | 6480464 | Copper Sulfate results in increased expression of FBXO2 mRNA | CTD | PMID:19549813 | cyclosporin A | increases expression | ISO | RGD:732900 | 6480464 | Cyclosporine results in increased expression of FBXO2 mRNA | CTD | PMID:20106945 | cyclosporin A | decreases expression | ISO | RGD:732900 | 6480464 | Cyclosporine results in decreased expression of FBXO2 mRNA | CTD | PMID:27989131 | cytarabine | decreases expression | ISO | RGD:732900 | 6480464 | Cytarabine results in decreased expression of FBXO2 mRNA | CTD | PMID:21198554 | dextran sulfate | increases expression | ISO | RGD:732901 | 6480464 | Dextran Sulfate results in increased expression of FBXO2 mRNA | CTD | PMID:35093514 | diazinon | decreases methylation | ISO | RGD:732900 | 6480464 | Diazinon results in decreased methylation of FBXO2 gene | CTD | PMID:22964155 | dibutyl phthalate | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of FBXO2 promoter | CTD | PMID:23359474 | dicrotophos | decreases expression | ISO | RGD:732900 | 6480464 | dicrotophos results in decreased expression of FBXO2 mRNA | CTD | PMID:28302478 | dieldrin | affects expression | EXP | | 6480464 | Dieldrin affects the expression of FBXO2 mRNA | CTD | PMID:22546817 | dorsomorphin | multiple interactions | ISO | RGD:732900 | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | elemental selenium | increases expression | ISO | RGD:732900 | 6480464 | Selenium results in increased expression of FBXO2 mRNA | CTD | PMID:19244175 | endosulfan | affects expression | EXP | | 6480464 | Endosulfan affects the expression of FBXO2 protein | CTD | PMID:31464424 | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of FBXO2 mRNA | CTD | PMID:31464424 | entinostat | multiple interactions | ISO | RGD:732900 | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FBXO2 mRNA | CTD | PMID:27188386 | entinostat | increases expression | ISO | RGD:732900 | 6480464 | entinostat results in increased expression of FBXO2 mRNA | CTD | PMID:26272509, PMID:27188386 | ethanol | multiple interactions | ISO | RGD:732900 | 6480464 | [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of FBXO2 mRNA | CTD | PMID:29432896 | ethanol | increases expression | ISO | RGD:732901 | 6480464 | Ethanol results in increased expression of FBXO2 mRNA | CTD | PMID:30319688 | flavonoids | increases expression | EXP | | 6480464 | Flavonoids results in increased expression of FBXO2 mRNA | CTD | PMID:18035473 | folic acid | multiple interactions | ISO | RGD:732901 | 6480464 | Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in decreased expression of FBXO2 mRNA] | CTD | PMID:22206623 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of FBXO2 mRNA | CTD | PMID:33387578 | isobutanol | multiple interactions | ISO | RGD:732900 | 6480464 | [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of FBXO2 mRNA | CTD | PMID:29432896 | ivermectin | decreases expression | ISO | RGD:732900 | 6480464 | Ivermectin results in decreased expression of FBXO2 protein | CTD | PMID:32959892 | ketamine | increases expression | EXP | | 6480464 | Ketamine results in increased expression of FBXO2 mRNA | CTD | PMID:20080153 | lead(0) | decreases expression | ISO | RGD:732900 | 6480464 | Lead results in decreased expression of FBXO2 mRNA | CTD | PMID:19921347 | lead(2+) | decreases expression | ISO | RGD:732900 | 6480464 | Lead results in decreased expression of FBXO2 mRNA | CTD | PMID:19921347 | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | increases expression | ISO | RGD:732901 | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of FBXO2 mRNA | CTD | PMID:25566086 | nickel dichloride | affects expression | EXP | | 6480464 | nickel chloride affects the expression of FBXO2 mRNA | CTD | PMID:22546817 | ozone | multiple interactions | ISO | RGD:732901 | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of FBXO2 mRNA, [Air Pollutants results in increased abundance of Ozone] which results in increased expression of FBXO2 mRNA | CTD | PMID:34911549 | panobinostat | multiple interactions | ISO | RGD:732900 | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FBXO2 mRNA | CTD | PMID:27188386 | panobinostat | increases expression | ISO | RGD:732900 | 6480464 | panobinostat results in increased expression of FBXO2 mRNA | CTD | PMID:26272509 | paracetamol | decreases expression | ISO | RGD:732900 | 6480464 | Acetaminophen results in decreased expression of FBXO2 mRNA | CTD | PMID:29067470 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of FBXO2 mRNA | CTD | PMID:33387578 | perfluorooctanoic acid | increases expression | ISO | RGD:732900 | 6480464 | perfluorooctanoic acid results in increased expression of FBXO2 protein | CTD | PMID:26879310 | propanal | increases expression | ISO | RGD:732900 | 6480464 | propionaldehyde results in increased expression of FBXO2 mRNA | CTD | PMID:26079696 | quercetin | increases expression | ISO | RGD:732900 | 6480464 | Quercetin results in increased expression of FBXO2 mRNA | CTD | PMID:21632981 | SB 431542 | multiple interactions | ISO | RGD:732900 | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | selenium atom | increases expression | ISO | RGD:732900 | 6480464 | Selenium results in increased expression of FBXO2 mRNA | CTD | PMID:19244175 | serpentine asbestos | increases expression | ISO | RGD:732900 | 6480464 | Asbestos, Serpentine results in increased expression of FBXO2 mRNA | CTD | PMID:21148743 | silicon dioxide | decreases expression | ISO | RGD:732900 | 6480464 | Silicon Dioxide analog results in decreased expression of FBXO2 mRNA | CTD | PMID:25895662 | silver atom | increases expression | ISO | RGD:732901 | 6480464 | Silver results in increased expression of FBXO2 mRNA | CTD | PMID:27131904 | silver(0) | increases expression | ISO | RGD:732901 | 6480464 | Silver results in increased expression of FBXO2 mRNA | CTD | PMID:27131904 | Soman | increases expression | EXP | | 6480464 | Soman results in increased expression of FBXO2 mRNA | CTD | PMID:19281266 | sulforaphane | decreases expression | ISO | RGD:732900 | 6480464 | sulforaphane results in decreased expression of FBXO2 mRNA | CTD | PMID:31838189 | sunitinib | increases expression | ISO | RGD:732900 | 6480464 | Sunitinib results in increased expression of FBXO2 mRNA | CTD | PMID:31533062 | T-2 toxin | affects expression | EXP | | 6480464 | T-2 Toxin affects the expression of FBXO2 protein | CTD | PMID:26141394 | trichostatin A | increases expression | ISO | RGD:732900 | 6480464 | trichostatin A results in increased expression of FBXO2 mRNA | CTD | PMID:24935251 | triclosan | increases expression | ISO | RGD:732900 | 6480464 | Triclosan results in increased expression of FBXO2 mRNA | CTD | PMID:30510588 | valproic acid | increases methylation | ISO | RGD:732900 | 6480464 | Valproic Acid results in increased methylation of FBXO2 gene | CTD | PMID:29154799 | valproic acid | increases expression | ISO | RGD:732901 | 6480464 | Valproic Acid results in increased expression of FBXO2 mRNA | CTD | PMID:21427059 | valproic acid | affects expression | ISO | RGD:732900 | 6480464 | Valproic Acid affects the expression of FBXO2 mRNA | CTD | PMID:25979313 | valproic acid | increases expression | ISO | RGD:732900 | 6480464 | Valproic Acid results in increased expression of FBXO2 mRNA | CTD | PMID:19101580 more ... | valproic acid | multiple interactions | ISO | RGD:732900 | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FBXO2 mRNA | CTD | PMID:27188386 | |